Transcription-coupled DNA double-strand breaks are mediated via the nucleotide excision repair and the Mre11-Rad50-Nbs1 complex.

The cellular activity of Yondelis (trabectedin, Ecteinascidin 743, Et743) is known to depend on transcription-coupled nucleotide excision repair (TCR). However, the subsequent cellular effects of Et743 are not fully understood. Here we show that Et743 induces both transcription- and replication-coupled DNA double-strand breaks (DSBs) that are detectible by neutral COMET assay and as gamma-H2AX foci that colocalize with 53BP1, Mre11, Ser(1981)-pATM, and Thr(68)-pChk2. The transcription coupled-DSBs (TC-DSBs) induced by Et743 depended both on TCR and Mre11-Rad50-Nbs1 (MRN) and were associated with DNA-PK-dependent gamma-H2AX foci. In contrast to DNA-PK, ATM phosphorylated H2AX both in NER-proficient and -deficient cells, but its full activation was dependent on H2AX as well as DNA-PK, suggesting a positive feedback loop: DNA-PK-gamma-H2AX-ATM. Knocking-out H2AX or inactivating DNA-PK reduced Et743's antiproliferative activity, whereas ATM and MRN tended to act as survival factors. Our results highlight the interplays between ATM and DNA-PK and their impacts on H2AX phosphorylation and cell survival. They also suggest that gamma-H2AX may serve as a biomarker in patients treated with Et743 and that molecular profiling of tumors for TCR, MRN, ATM, and DNA-PK might be useful to anticipate tumor response to Et743 treatment.

[1]  Fengqin Gao,et al.  Bcl2 negatively regulates DNA double-strand-break repair through a nonhomologous end-joining pathway. , 2008, Molecular cell.

[2]  Y. Pommier,et al.  Bloom's syndrome helicase and Mus81 are required to induce transient double-strand DNA breaks in response to DNA replication stress. , 2008, Journal of molecular biology.

[3]  Jiri Bartek,et al.  Human CtIP promotes DNA end resection , 2007, Nature.

[4]  Y. Pommier,et al.  The Mammalian DNA Replication Elongation Checkpoint: Implication of Chk1 and Relationship with Origin Firing as Determined by Single DNA Molecule and Single Cell Analyses , 2007, Cell cycle.

[5]  P. Russell,et al.  Ctp1 is a cell-cycle-regulated protein that functions with Mre11 complex to control double-strand break repair by homologous recombination. , 2007, Molecular cell.

[6]  K. Sugasawa Xeroderma pigmentosum genes: functions inside and outside DNA repair. , 2007, Carcinogenesis.

[7]  A. Escargueil,et al.  Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743 , 2007, Proceedings of the National Academy of Sciences.

[8]  K. Cimprich,et al.  The ATR pathway: fine-tuning the fork. , 2007, DNA repair.

[9]  Y. Pommier,et al.  Endogenous γ-H2AX-ATM-Chk2 Checkpoint Activation in Bloom's Syndrome Helicase–Deficient Cells Is Related to DNA Replication Arrested Forks , 2007, Molecular Cancer Research.

[10]  Y. Pommier,et al.  The Intra-S-Phase Checkpoint Affects both DNA Replication Initiation and Elongation: Single-Cell and -DNA Fiber Analyses , 2007, Molecular and Cellular Biology.

[11]  Y. Pommier,et al.  Defective Mre11-dependent Activation of Chk2 by Ataxia Telangiectasia Mutated in Colorectal Carcinoma Cells in Response to Replication-dependent DNA Double Strand Breaks* , 2006, Journal of Biological Chemistry.

[12]  S. Moreno,et al.  Cross-talk between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin. , 2006, Cancer research.

[13]  Yong-Yeon Cho,et al.  Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. , 2006, Molecular cell.

[14]  Y. Shiloh The ATM-mediated DNA-damage response: taking shape. , 2006, Trends in biochemical sciences.

[15]  V. Natale,et al.  H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[16]  David J. Chen,et al.  DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. , 2006, DNA repair.

[17]  Jean Gautier,et al.  Two-step activation of ATM by DNA and the Mre11–Rad50–Nbs1 complex , 2006, Nature Structural &Molecular Biology.

[18]  F. Alt,et al.  MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. , 2006, Molecular cell.

[19]  M. Yaffe,et al.  MDC1 Directly Binds Phosphorylated Histone H2AX to Regulate Cellular Responses to DNA Double-Strand Breaks , 2005, Cell.

[20]  J. Blay,et al.  ET-743: a novel agent with activity in soft tissue sarcomas. , 2005, The oncologist.

[21]  E. Sausville,et al.  DNA-protein cross-links and replication-dependent histone H2AX phosphorylation induced by aminoflavone (NSC 686288), a novel anticancer agent active against human breast cancer cells. , 2005, Cancer research.

[22]  Karl-Heinz Krause,et al.  BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase , 2005, Oncogene.

[23]  Ji-Hoon Lee,et al.  ATM Activation by DNA Double-Strand Breaks Through the Mre11-Rad50-Nbs1 Complex , 2005, Science.

[24]  Stephen P. Jackson,et al.  Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage , 2005, Nature.

[25]  Y. Pommier,et al.  Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery. , 2005, Trends in pharmacological sciences.

[26]  I. Hardcastle,et al.  Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries. , 2004, Bioorganic & medicinal chemistry letters.

[27]  N. Curtin,et al.  Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM , 2004, Cancer Research.

[28]  H. Tauchi,et al.  NBS1 and its functional role in the DNA damage response. , 2004, DNA repair.

[29]  A. Sancar,et al.  Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. , 2004, Annual review of biochemistry.

[30]  J. Bartek,et al.  Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation , 2004, Oncogene.

[31]  J. Manola,et al.  Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  M. Weitzman,et al.  Structural and functional analysis of Mre11-3. , 2004, Nucleic acids research.

[33]  M. D’Incalci,et al.  Preclinical and clinical results with the natural marine product ET-743 , 2003, Expert opinion on investigational drugs.

[34]  Yair Andegeko,et al.  Requirement of the MRN complex for ATM activation by DNA damage , 2003, The EMBO journal.

[35]  Y. Pommier,et al.  Phosphorylation of Histone H2AX and Activation of Mre11, Rad50, and Nbs1 in Response to Replication-dependent DNA Double-strand Breaks Induced by Mammalian DNA Topoisomerase I Cleavage Complexes* , 2003, Journal of Biological Chemistry.

[36]  David A. Boothman,et al.  Ku70 suppresses the apoptotic translocation of Bax to mitochondria , 2003, Nature Cell Biology.

[37]  M. Kastan,et al.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation , 2003, Nature.

[38]  G. Demetri,et al.  Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity , 2002, Cancer Chemotherapy and Pharmacology.

[39]  M. Weitzman,et al.  Adenovirus oncoproteins inactivate the Mre11–Rad50–NBS1 DNA repair complex , 2002, Nature.

[40]  Yves Pommier,et al.  Ecteinascidin 743: a novel anticancer drug with a unique mechanism of action , 2002, Anti-cancer drugs.

[41]  P. C. Lee,et al.  DNA damage‐induced apoptosis requires the DNA‐dependent protein kinase, and is mediated by the latent population of p53 , 2004 .

[42]  K. Scotto,et al.  Ecteinascidin-743 inhibits activated but not constitutive transcription. , 2002, Cancer research.

[43]  S. Jackson,et al.  The MRE11 complex: at the crossroads of DNA repair and checkpoint signalling , 2002, Nature Reviews Molecular Cell Biology.

[44]  Michel C. Nussenzweig,et al.  Genomic Instability in Mice Lacking Histone H2AX , 2002, Science.

[45]  E. Rogakou,et al.  Histone H2A variants H2AX and H2AZ. , 2002, Current opinion in genetics & development.

[46]  Alessandra Viel,et al.  Human MRE11 is inactivated in mismatch repair‐deficient cancers , 2002, EMBO reports.

[47]  D. Bearss,et al.  The inefficiency of incisions of ecteinascidin 743-DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent. , 2001, Chemistry & biology.

[48]  C. Verschraegen,et al.  ET-743 (PharmaMar/NCI/Ortho Biotech). , 2001, Current opinion in investigational drugs.

[49]  J. Hoeijmakers,et al.  Molecular mechanisms of nucleotide excision repair , 2001 .

[50]  Y. Pommier,et al.  Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair , 2001, Nature Medicine.

[51]  R. Hindges,et al.  Double‐check probing of DNA bending and unwinding by XPA–RPA: an architectural function in DNA repair , 2001, The EMBO journal.

[52]  M. D’Incalci,et al.  Unique pattern of ET‐743 activity in different cellular systems with defined deficiencies in DNA‐repair pathways , 2001, International journal of cancer.

[53]  B. M. Forman,et al.  The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux , 2001, Nature Medicine.

[54]  T. Halazonetis,et al.  P53 Binding Protein 1 (53bp1) Is an Early Participant in the Cellular Response to DNA Double-Strand Breaks , 2000, The Journal of cell biology.

[55]  R. Mantovani,et al.  Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Y. Pommier,et al.  Conversion of Topoisomerase I Cleavage Complexes on the Leading Strand of Ribosomal DNA into 5′-Phosphorylated DNA Double-Strand Breaks by Replication Runoff , 2000, Molecular and Cellular Biology.

[57]  C. Ling,et al.  The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[58]  L. Hurley,et al.  Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove. , 1999, Journal of medicinal chemistry.

[59]  W. de Laat,et al.  Molecular mechanism of nucleotide excision repair. , 1999, Genes & development.

[60]  E. Raymond,et al.  In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[61]  W. de Laat,et al.  DNA-binding polarity of human replication protein A positions nucleases in nucleotide excision repair. , 1998, Genes & development.

[62]  M. D’Incalci,et al.  Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[63]  Yosef Shiloh,et al.  Recombinant ATM protein complements the cellular A-T phenotype , 1997, Oncogene.

[64]  K. Kohn,et al.  DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata. , 1996, Biochemistry.

[65]  R. Sakai,et al.  Molecular and crystal structures of ecteinascidins: potent antitumor compounds from the Caribbean tunicate Ecteinascidia turbinata. , 1993, Journal of biomolecular structure & dynamics.

[66]  R. Sakai,et al.  Additional antitumor ecteinascidins from a Caribbean tunicate: crystal structures and activities in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Paul A. Keifer,et al.  Bioactive Compounds from Aquatic and Terrestrial Sources , 1991 .

[68]  J. Petrini,et al.  DNA replication-dependent nuclear dynamics of the Mre11 complex. , 2003, Molecular cancer research : MCR.

[69]  Y. Pommier,et al.  Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expression. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[70]  M D'Incalci,et al.  Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action. , 2001, European journal of cancer.